LPGAT1
Acyl-CoA:lysophosphatidylglycerol acyltransferase 1
Also known as: FAM34A, FAM34A1, KIAA0205, LGAT1_HUMAN, LPLAT7, NET8
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q92604
- Gene
- LPGAT1
- Ensembl
- ENSG00000123684
- Chromosome
- 1
- Canonical length
- 370 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a member of the lysophospholipid acyltransferase family. The encoded protein catalyzes the reacylation of lysophosphatidylglycerol to phosphatidylglycerol, a membrane phospholipid that is an important precursor for the synthesis of cardiolipin. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]
Canonical amino-acid sequenceUniProt
370 residues, UniProt reviewed canonical sequence.
>Q92604|LPGAT1
1 MAITLEEAPW LGWLLVKALM RFAFMVVNNL VAIPSYICYV IILQPLRVLD SKRFWYIEGI
61 MYKWLLGMVA SWGWYAGYTV MEWGEDIKAV SKDEAVMLVN HQATGDVCTL MMCLQDKGLV
121 VAQMMWLMDH IFKYTNFGIV SLVHGDFFIR QGRSYRDQQL LLLKKHLENN YRSRDRKWIV
181 LFPEGGFLRK RRETSQAFAK KNNLPFLTNV TLPRSGATKI ILNALVAQQK NGSPAGGDAK
241 ELDSKSKGLQ WIIDTTIAYP KAEPIDIQTW ILGYRKPTVT HVHYRIFPIK DVPLETDDLT
301 TWLYQRFVEK EDLLSHFYET GAFPPSKGHK EAVSREMTLS NLWIFLIQSF AFLSGYMWYN
361 IIQYFYHCLFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LPGAT1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 38 nTPM
Expression across tissuesHPA
Tissue
- retina: 38 nTPM
- liver: 34 nTPM
- small intestine: 33 nTPM
- thyroid gland: 24 nTPM
- duodenum: 22 nTPM
- testis: 21 nTPM
Single-cell type
- neutrophils: 900 nCPM
- neutrophil progenitors: 707 nCPM
- oligodendrocytes: 663 nCPM
- early spermatids: 640 nCPM
- choroid plexus epithelial cells: 530 nCPM
- retinal pigment epithelial cells: 405 nCPM
Immune cell
- eosinophil: 16 nTPM
- basophil: 12 nTPM
- neutrophil: 12 nTPM
- NK-cell: 5.3 nTPM
- myeloid DC: 3.2 nTPM
- classical monocyte: 2.7 nTPM
Brain region
- white matter: 94 nTPM
- basal ganglia: 76 nTPM
- midbrain: 65 nTPM
- choroid plexus: 61 nTPM
- thalamus: 61 nTPM
- cerebral cortex: 60 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about LPGAT1.
Disease | ImmuneIEDB
Conditions an epitope on LPGAT1 was assayed in.
- bladder carcinoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.3
- gnomAD pLI
- 0.98
- gnomAD missense Z
- 2.39
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- phosphatidylethanolamine acyl-chain remodeling
- phosphatidylglycerol acyl-chain remodeling
- phosphatidylinositol acyl-chain remodeling
- phospholipid biosynthetic process
- positive regulation of fatty acid biosynthetic process
- triglyceride biosynthetic process
Molecular functions
- 1-acylglycerol-3-phosphate O-acyltransferase activity
- 2-acylglycerol O-acyltransferase activity
- 2-acylglycerol-3-phosphate O-acyltransferase activity
- acyltransferase activity
- lysophospholipid acyltransferase activity
- 2-acylglycerophosphocholine O-acyltransferase activity
- lysophosphatidylethanolamine acyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LPGAT1 as an antibody target. Whether an autoantibody or antibody against LPGAT1 could matter depends on whether native LPGAT1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LPGAT1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LPGAT1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...